CXCL10 and COVID-19: Similarly to COVID-19, in other ARVIs, the levels of IFNγ-inducible CXCL10 in BAL and plasma correlate with the severity of the disease (Hayney et al., 2017; Almansa et al., 2011; Buszko et al., 2020).